Direct in vitro evidence and in vivo analysis of the antiangiogenesis effects of interleukin 12

Cancer Research

Volumn 60, Issue 4, 2000, Pages 1111-1116

  Duda, Dan Gabriel ^a   Sunamura, Makoto ^a   Lozonschi, Lucian ^a   Kodama, Tomohiro ^a   Egawa, Shin Ichi ^a   Matsumoto, Gaku ^a   Shimamura, Hiromune ^a   Shibuya, Kazuhiko ^a   Takeda, Kazunori ^a   Matsuno, Seiki ^a  

^a TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS INHIBITOR; BASIC FIBROBLAST GROWTH FACTOR; INTERLEUKIN 12; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL CELL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXIC T LYMPHOCYTE; HUMAN; HUMAN CELL; IMMUNOREGULATION; KERATINIZATION; MALE; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; TISSUE NECROSIS; TUMOR VASCULARIZATION;

3T3 CELLS; ANGIOGENESIS INHIBITORS; ANIMALS; CYTOKINES; HUMANS; INTERLEUKIN-12; MALE; MICE; MICE, SCID; NEOPLASMS, EXPERIMENTAL; NEOVASCULARIZATION, PATHOLOGIC; TUMOR CELLS, CULTURED;

EID: 0034652459     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Wolf, S. F., Temple, P. A., Kobayashi, M., Young, D., Dicig, M., Lowe, L., Dzialo, R., Fitz. L., Ferenz, C., Hewick, R. M., Kelleher, K., Herrmann, S. H., Clark, S. C., Azzoni, L., Chan, S. H., Trinchieri, G., and Perussia, B. Cloning of cDNA for natural killer cell stimulalory factor, a heterodimeric cytokine with multiple biologic effects on T and natural killer cells. J. Immunol., 146: 3074-3081, 1991.
2. McKnight, A. J., Zimmer, G. J., Fogelman, I., Wolf, S. F., and Abbas, A. K. Effects of IL-12 on helper T cell-dependent immune responses in vivo. J. Immunol., 152: 2172-2179, 1994.
3. Trinchieri, G. Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Annu. Rev. Immunol., 13: 251-276, 1995.
4. Lotze, M. T., Hellerstedt, B., Stolinski, L., Tueting, T., Wilson, C., Kinzler, D., Vu, H., Rubin, J. T., Storkus, W., Tahara, H., Elder, E., and Whiteside, T. The role of interleukin-2, interleukin-12, and dendritic cells in cancer therapy. Cancer J. Sci. Am., 1 (Suppl.): S109-S114, 1997.
5. Ohe, Y., Kasai, T., Heike, Y., and Saijo, N. Clinical trial of IL-12 for cancer patients. Gan To Kagaku Ryoho, 25: 177-184, 1998.
6. Voest, E. E., Kenyon, B. M., O'Reilly, M. S., Truitt, G., D'Amato, R. J., and Folkman, J. Inhibition of angiogenesis in vivo by interleukin 12. Int. J. Cancer, 78: 361-365, 1998.
7. Dias, S., Boyd, R., and Balkwill, F. IL-12 regulates VEGF and MMPs in a murine breast cancer model. J. Natl. Cancer Inst., 87: 581-586, 1995.
8. Yao, L., Sgadari, C., Furuke, K., Bloom, E. T., Teruya-Feldstein, J., and Tosato, G. Contribution of natural killer cells to inhibition of angiogenesis by Interleukin-12. Blood, 93: 1612-1621, 1999.
9. Habu, S., Fukui, H., Shimamura, K., Kasai, M., Nagai, Y., Okumura, K., and Tamaoki, N. In vivo effects of anti-asialo GM1. I. Reduction of NK activity and enhancement of transplanted tumor growth in nude mice. J. Immunol., 127: 34-38, 1981.
10. Kobari, M., Matsuno, S., Sato, T., Kan, M., and Tachibana, T. Establishment of a human pancreatic cancer cell line and detection of pancreatic cancer associated antigen. Tohoku J. Exp. Med., 143: 33-46, 1984.
11. Zitvogel, L., Tahara, H., Cai, Q., Storkus, W. J., Muller, G., Wolf, S. F., Gately, M., Robbins, P. D., and Lotze, M. T. Construction and characterization of retroviral vectors expressing biologically active human interleukin-12. Hum. Gene Ther., 5: 1493-1506, 1994.
12. Matsumoto, G., Sunamura, M., Shimamura, H., Kodama, T., Hashimoto, W., Kobari, M., Kato, K., Takeda, K., Yagita, H., Okumura, K., Hamada, H., and Matsuno, S. Adjuvant immunotherapy using fibroblasts genetically engineered to secrete interleukin 12 prevents recurrence after surgical resection of established tumors in a murine adenocarcinoma model. Surgery, 125: 257-264, 1999.
13. 2+-independent adhesion pathway in lymphocyte-endothelial cell interaction. Eur. J. Immunol., 23: 439-446, 1993.
14. Lehr, H. A., Leunig, M., Menger, M. D., Nolte, D., and Messmer, K. Dorsal skinfold chamber technique for intravital microscopy in nude mice. Am. J. Pathol., 143: 1055-1062, 1993.
15. Lozonschi, L., Sunamura, M., Kobari, M., Egawa, S., Ding, L., and Matsuno, S. Controlling tumor angiogenesis and metastasis of C26 murine colon adenocarcinoma by a new matrix metalloproteinase inhibitor, KB-R7785, in two tumor models. Cancer Res., 59: 1252-1258, 1999.
16. Ohtani, H., and Sasano, N. Microvascular changes in the stroma of human colorectal carcinomas: ultrastructural histochemical study. Jpn. J. Cancer Res., 80: 360-365, 1989.
17. Sahin, A. A., Ro, J., Ro, J. Y., Blick, M. B., el-Naggar, A. K., Ordonez, N. G., Fritsche, H. A., Smith, T. L., Hortobagyi, G. N., and Ayala, A. G. Ki-67 immunostaining in node-negative stage I/II breast carcinoma. Significant correlation with prognosis. Cancer (Phila.), 68: 549-557, 1991.
18. Folkman, J. Tumor angiogenesis. Adv. Cancer Res., 43: 175-203, 1985.
19. Brunda, M. J., Luistro, L., Warrier, R. R., Wright, R. B., Hubbard, B. R., Murphy, M., Wolf, S. F., and Gately, M. K. Antitumor and antimetastatic activity of interleukin 12 against murine tumors. J. Exp. Med., 178: 1223-1230, 1993.
20. Nastala, C. L., Edington, H. D., McKinney, T. G., Tahara, H., Nalesnik, M. A., Brunda, M. J., Gately, M. K., Wolf, S. F., Schreiber, R. D., Storkus, W. J., and Lotze, M. T. Recombinant IL-12 administration induces tumor regression in association with IFN-γ production. J. Immunol., 153: 1697-1706, 1994.
21. Kanegane, C., Sgadari, C., Kanegane, H., Teruya-Feldstein, J., Yao, L., Gupta, G., Farber, J. M., Liao, F., Liu, L., and Tosalo, G. Contribution of the CXC chemokines IP-10 and Mig to the antitumor effects of IL-12. Int. J. Cancer, 78: 361-365, 1998.
22. Sgadari, C., Angiolillo, A. L., and Tosato, G. Inhibition of angiogenesis by interleukin-12 is mediated by the interferon-inducible protein 10. Blood, 87: 3877-3882, 1996.
23. Coughlin, C. M., Salhany, K. E., Wysocka, M., Aruga, E., Kurzawa, H., Chang, A. E., Hunter, C. A., Fox, J. C., Trinchieri, G., and Lee, W. M. F. Interleukin-12 and interleukin-18 synergistically induce murine tumor regression which involves inhibition of angiogenesis. J. Clin. Investig., 101: 1441-1452, 1998.
24. Tahara, H., Zeh, H. J., III, Storkus, W. J., Pappo, I., Watkins, S. C., Gubler, U., Wolf, S. F., Robbins, P. D., and Lotze, M. T. Fibroblasts genetically engineered to secrete interleukin 12 can suppress tumor growth and induce antitumor immunity to a murine melanoma in vivo. Cancer Res., 54: 182-189, 1994.
25. Caruso, M., Pham-Nguyen, K., Kwong, Y. L., Xu, B., Kosai, K. I., Finegold, M., Woo, S. L., and Chen, S. H. Adenovirus-mediated interleukin-12 gene therapy for metastatic colon carcinoma. Proc. Natl. Acad. Sci. USA, 93: 11302-11306, 1996.
26. Bramson, J. L., Hitt, M., Addison, C. L., Muller, W. J., Gauldie, J. and Graham, F. L. Direct intratumoral injection of an adenovirus expressing interleukin-12 induces regression and long-lasting immunity that is associated with highly localized expression of interleukin-12. Hum. Gene Ther., 7: 1995-2002, 1996.